Fda Approves Lilly, Boehringer Diabetes Drug

The drug is designed to be taken once a day to reduce a patient's blood sugar levels by blocking glucose reabsorption.

Topics:  drug   
BING NEWS:
  • Jardiance and Ofev propel Boehringer’s human pharma sales
    The German company announced that it had reached €20.8bn ($22.1bn) in human pharma sales in 2023, also achieving a 14.2% boost in research and development (R&D) investments that reached €5.8bn.
    04/16/2024 - 7:29 am | View Link
  • FDA approves first prescription-only app for depression
    Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...
    04/5/2024 - 10:26 am | View Link
  • Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says
    Amid steadily increasing demand for Eli Lilly’s popular diabetes med Mounjaro, it appears patients on multiple dose strengths may have to wait even longer than anticipated to re-up on supply.
    04/2/2024 - 6:12 am | View Link
  • U.S. FDA approves Akebia's anemia drug
    , opens new tab drug, vadadustat, to treat anemia caused by chronic kidney disease (CKD) in dialysis patients, the drugmaker said on Wednesday. The drug will be available under the brand name ...
    03/28/2024 - 3:17 am | View Link
  • US FDA approves Merck's therapy for rare lung condition
    March 26 (Reuters) - (This March 26 story has been corrected to remove reference to follicle-stimulating hormone, in paragraph 8) The U.S. Food and Drug Administration on Tuesday approved Merck's ...
    03/27/2024 - 6:20 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News